14 juin

Eur Heart J https://academic.oup.com/site_5375/

• 02:00
  BNP as a biomarker in adult congenital heart disease: help or hype? Eur Heart J
  Graphical AbstractGraphical AbstractRelationships of BNP to Mortality in Adult Congenital Heart Disease (L) and in Chronic Non-Congenital Heart Failure (R)Across 9 categories of Adult Congenital Heart Disease (ACHD) mortality varied over a 10-fold range.Baseline median BNP values over the 9 (…)
• 02:00
  The evolving management of adult congenital heart disease: focus on biomarkers and cardiac magnetic resonance Eur Heart J

7 juin

Eur Heart J https://academic.oup.com/site_5375/

• 02:00
  Focus on emerging cancer drugs, artificial intelligence applied to imaging, and a new therapeutic target in heart failure Eur Heart J

5 juin

Eur Heart J https://academic.oup.com/site_5375/

• 02:00
  When cardiovascular medicines should be discontinued Eur Heart J
  AbstractAn integral component of the practice of medicine is focused on the initiation of medications, based on clinical practice guidelines and underlying trial evidence, which usually test the addition of novel medications intended for life-long use in short-term clinical trials. Much less (…)

1er juin

Eur Heart J https://academic.oup.com/site_5375/

• 02:00
  Optimizing the treatment of severe aortic stenosis Eur Heart J

31 mai

Eur Heart J https://academic.oup.com/site_5375/

• 02:00
  An initial invasive strategy in older patients with non-ST elevation acute coronary syndromes: it is never too late Eur Heart J
  Graphical AbstractGraphical AbstractOutcomes with invasive vs. conservative strategies in older patients with NSTE-ACS. Damman et al. reported aggregated results from FRISC-II, ICTUS and RITA3 trials in patients ?75 years, Tegn et al. (After Eighty trial) enrolled exclusively patients ?80 years, (…)
• 02:00
  Transfemoral aortic valve implantation and concomitant CAD: the jury is out Eur Heart J

28 mai

Eur Heart J https://academic.oup.com/site_5375/

• 02:00
  Contemporary outcomes in patients hospitalized with pulmonary embolism: what can we learn from observational data? Eur Heart J

27 mai

Eur Heart J https://academic.oup.com/site_5375/

• 02:00
  Correction to: Severe aortic stenosis: secular trends of incidence and outcomes Eur Heart J
  This is a correction to:
• 02:00
  The growing role of coronary computed tomography angiography, polygenic risk scores and electronic nudges in the management of ischaemic heart disease Eur Heart J
• 02:00
  Fifty years of percutaneous transluminal angioplasty Eur Heart J
  This year marks the 50th anniversary of the first balloon percutaneous transluminal angioplasty (PTA), a landmark event in cardiovascular medicine. This technique was invented by Andreas Roland Grüntzig, a German angiologist who performed it for the first time on 12 February 1974, in Zurich, (...)

24 mai

Eur Heart J https://academic.oup.com/site_5375/

• 02:00
  Taking the sex out of atrial fibrillation Eur Heart J

23 mai

Eur Heart J https://academic.oup.com/site_5375/

• 02:00
  A non-invasive gateway to identifying potential substrates for macro-reentrant ventricular tachycardia in tetralogy of Fallot Eur Heart J
  Graphical AbstractGraphical Abstract

21 mai

Eur Heart J https://academic.oup.com/site_5375/

• 02:00
  The grey areas in anticoagulation for stroke prevention and a focus on chronic stress in carotid atherosclerosis Eur Heart J
• 02:00
  Cortico-limbic restructuring and atherosclerosis: a stressful liaison Eur Heart J

16 mai

Eur Heart J https://academic.oup.com/site_5375/

• 02:00
  Cortico-limbic interactions and carotid atherosclerotic burden during chronic stress exposure Eur Heart J
  AbstractBackground and AimsChronic stress associates with cardiovascular disease, but mechanisms remain incompletely defined. Advanced imaging was used to identify stress-related neural imaging phenotypes associated with atherosclerosis.MethodsTwenty-seven individuals with post-traumatic (...)

15 mai

Eur Heart J https://academic.oup.com/site_5375/

• 02:00
  Three-dimensional cardiac magnetic resonance allows the identification of slow-conducting anatomical isthmuses in tetralogy of Fallot Eur Heart J
  AbstractBackground and AimsPatients with repaired tetralogy of Fallot remain at risk of life-threatening ventricular tachycardia related to slow-conducting anatomical isthmuses (SCAIs). Preventive ablation of SCAI identified by invasive electroanatomical mapping is increasingly performed. This (…)

14 mai

Eur Heart J https://academic.oup.com/site_5375/

• 02:00
  B-type natriuretic peptide levels predict long-term mortality in a large cohort of adults with congenital heart disease Eur Heart J
  AbstractBackground and AimsMany adult patients with congenital heart disease (ACHD) are still afflicted by premature death. Previous reports suggested natriuretic peptides may identify ACHD patients with adverse outcome. The study investigated prognostic power of B-type natriuretic peptide (BNP) (…)
• 02:00
  Arrhythmic risk in young women with mitral valve prolapse: keep your eyes open but don’t jump at every shadow Eur Heart J
• 02:00
  Mitral valve prolapse: arrhythmic risk during pregnancy and postpartum Eur Heart J
  AbstractBackground and AimsArrhythmic mitral valve prolapse (AMVP) is linked to life-threatening ventricular arrhythmias (VAs), and young women are considered at high risk. Cases of AMVP in women with malignant VA during pregnancy have emerged, but the arrhythmic risk during pregnancy is (...)

13 mai

Eur Heart J https://academic.oup.com/site_5375/

• 02:00
  Focus on ischaemic heart disease: prevention with colchicine, role of the brain–heart axis, new therapeutic targets for ischaemia–reperfusion injury Eur Heart J

10 mai

Eur Heart J https://academic.oup.com/site_5375/

• 02:00
  Correction to: Tackling cardiovascular healthcare disparities for the LGBTQIA+ population: a call to action Eur Heart J
  This is a correction to: Alexander Kharlamov, Nigel Sherriff, Christian Delles, Pim van der Harst, Tackling cardiovascular healthcare disparities for the LGBTQIA+ population: a call to action, European Heart Journal, Volume 45, Issue 15, 14 April 2024, Pages 1291–1294, (…)

9 mai

Eur Heart J https://academic.oup.com/site_5375/

• 02:00
  Correction to: Implantable loop recorders in patients with Brugada syndrome: the BruLoop study Eur Heart J
  This is a correction to: Marco Bergonti, Frederic Sacher, Elena Arbelo, Lia Crotti, Avi Sabbag, Michela Casella, Johan Saenen, Andrea Rossi, Cinzia Monaco, Luigi Pannone, Paolo Compagnucci, Vincenzo Russo, Eyal Heller, Amato Santoro, Paola Berne, Antonio Bisignani, Enrico Baldi, Olivier Van (…)

7 mai

Eur Heart J https://academic.oup.com/site_5375/

• 02:00
  Non-traditional risk factors: built environment assessed by Google Street View, syphilis, and rheumatoid arthritis Eur Heart J

2 mai

Eur Heart J https://academic.oup.com/site_5375/

• 02:00
  Lower extremity arterial disease vs. coronary artery disease: mortality differences after revascularization Eur Heart J
  AbstractBackground and AimsPatients undergoing revascularization for lower extremity arterial disease (LEAD) may face a higher risk of mortality than those with coronary artery disease (CAD). This study aimed to characterize the difference in mortality risk between patients undergoing (...)

30 avril

Eur Heart J https://academic.oup.com/site_5375/

• 02:00
  Embolic strokes of undetermined source: a clinical consensus statement of the ESC Council on Stroke, the European Association of Cardiovascular Imaging and the European Heart Rhythm Association of the ESC Eur Heart J
  AbstractOne in six ischaemic stroke patients has an embolic stroke of undetermined source (ESUS), defined as a stroke with unclear aetiology despite recommended diagnostic evaluation. The overall cardiovascular risk of ESUS is high and it is important to optimize strategies to prevent (...)
• 02:00
  Caring for patients with lower extremity artery disease: going beyond stents and bypass grafts Eur Heart J

26 avril

Eur Heart J https://academic.oup.com/site_5375/

• 02:00
  In memoriam: Alain Cribier Eur Heart J
• 02:00
  Transcatheter aortic valve replacement: benchmarking practices to optimize quality and outcomes Eur Heart J
• 02:00
  Insights into the influence of income variability on cardiovascular risk in non-elderly adults with type 2 diabetes Eur Heart J
• 02:00
  Income variability and incident cardiovascular disease in diabetes: a population-based cohort study Eur Heart J
  AbstractBackground and AimsLongitudinal change in income is crucial in explaining cardiovascular health inequalities. However, there is limited evidence for cardiovascular disease (CVD) risk associated with income dynamics over time among individuals with type 2 diabetes (T2D).MethodsUsing a (...)
• 02:00
  Aspirin hypersensitivity: a practical guide for cardiologists Eur Heart J
  AbstractAspirin has been known for a long time and currently stays as a cornerstone of antithrombotic therapy in cardiovascular disease. In patients with either acute or chronic coronary syndromes undergoing percutaneous coronary intervention aspirin is mandatory in a dual antiplatelet therapy (...)
• 02:00
  Myocardial reperfusion injury exacerbation due to ALDH2 deficiency is mediated by neutrophil extracellular traps and prevented by leukotriene C4 inhibition Eur Heart J
  AbstractBackground and AimsThe Glu504Lys polymorphism in the aldehyde dehydrogenase 2 (ALDH2) gene is closely associated with myocardial ischaemia/reperfusion injury (I/RI). The effects of ALDH2 on neutrophil extracellular trap (NET) formation (i.e. NETosis) during I/RI remain unknown. This (...)
• 02:00
  Repurposing of an antiasthmatic drug may reduce NETosis and myocardial ischaemia/reperfusion injury Eur Heart J

17 avril

Eur Heart J https://academic.oup.com/site_5375/

• 02:00
  Correction to: XANTUS: a real-world, prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation Eur Heart J
  This is a correction to: A. John Camm, Pierre Amarenco, Sylvia Haas, Susanne Hess, Paulus Kirchhof, Silvia Kuhls, Martin van Eickels, Alexander G.G. Turpie, the XANTUS Investigators, XANTUS: a real-world, prospective, observational study of patients treated with rivaroxaban for stroke (...)
• 02:00
  The ‘Ten Commandments’ for the 2023 European Society of Cardiology guidelines for the management of endocarditis Eur Heart J
  The 2023 European Society of Cardiology (ESC) Guidelines for the Management of Endocarditis were developed by the ESC Endocarditis Task Force, which consisted of multi-disciplinary experts involved in the management of patients with infectious endocarditis (IE) and were endorsed by the (...)
• 02:00
  The year in cardiovascular medicine 2023: the top 10 papers in arrhythmias Eur Heart J
• 02:00
  Genetic testing in patients with unexplained coronary aneurysms or dilation Eur Heart J

16 avril

Eur Heart J https://academic.oup.com/site_5375/

• 02:00
  Correction to: Anthracycline therapy induces an early decline of cardiac contractility with transient edema in low risk patients with breast cancer Eur Heart J
  This is a correction to: F Voss, F Nienhaus, S Pietrucha, T Melz, M Cramer, S M Haberkorn, E Ruckhaeberle, T Fehm, U Floegel, W Westenfeld, D Scheiber, C Jung, M Kelm, A Polzin, F Boenner, Anthracycline therapy induces an early decline of cardiac contractility with transient edema in low risk (...)

15 avril

Eur Heart J https://academic.oup.com/site_5375/

• 02:00
  Weekly journal scan: excess incidence of unexpected health outcomes following myocardial infarction—broader paths for secondary prevention Eur Heart J
  Comment on the article ‘Health outcomes after myocardial infarction: a population study of 56 million people in England’ which was published in PloS Medicine, https://doi.org/10.1371/journal.pmed.1004343.1
• 02:00
  Obesity: an overlooked player in cardiological practice and the need for urgent action Eur Heart J

12 avril

Eur Heart J https://academic.oup.com/site_5375/

• 02:00
  The Nordic Cardio-Oncology Society: mission and future goals Eur Heart J
  Based on a common wish to unite oncologists/haematologists and cardiologists and improve collaboration, the Nordic Cardio-Oncology Society (NCOS) is an encouragement for shared medical knowledge and performance of high-quality research with high clinical impact.
• 02:00
  Ischaemic stroke in women with atrial fibrillation: temporal trends and clinical implications Eur Heart J
  AbstractBackground and AimsFemale sex has been linked with higher risk of ischaemic stroke (IS) in atrial fibrillation (AF), but no prior study has examined temporal trends in the IS risk associated with female sex.MethodsThe registry-linkage Finnish AntiCoagulation in Atrial Fibrillation (...)
• 02:00
  Sing for a long and healthy life? Eur Heart J
• 02:00
  Atherosclerosis evaluation and cardiovascular risk estimation using coronary computed tomography angiography Eur Heart J
  AbstractClinical risk scores based on traditional risk factors of atherosclerosis correlate imprecisely to an individual’s complex pathophysiological predisposition to atherosclerosis and provide limited accuracy for predicting major adverse cardiovascular events (MACE). Over the past two (...)
• 02:00
  Polygenic risk scores for cardiovascular risk prediction: moving towards implementation into clinical practice? Eur Heart J
• 02:00
  Peripheral artery disease and outcomes: how can we improve risk prediction? Eur Heart J
• 02:00
  Rising stars in cardiology: Tobias Harm Eur Heart J
  Tobias Harm, MD, from the University of Tübingen, Germany has been making waves with his research aiming to transform risk prediction and treatment strategies for cardiovascular diseases. The aspiring clinician–scientist received the Young Investigator Award (YIA) for Thrombosis at the 2023 (...)

10 avril

Eur Heart J https://academic.oup.com/site_5375/

• 02:00
  Invasive vs. conservative management of older patients with non-ST-elevation acute coronary syndrome: individual patient data meta-analysis Eur Heart J
  AbstractBackground and AimsOlder patients with non-ST-elevation acute coronary syndrome (NSTEACS) are less likely to receive guideline-recommended care including coronary angiography and revascularization. Evidence-based recommendations regarding interventional management strategies in this (…)
• 02:00
  Weekly journal scan: angina severity reduced by percutaneous coronary intervention in the ORBITA-2 trial Eur Heart J
  Comment on the article ‘A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable Angina’ which was published in the New England Journal of Medicine, https://doi.org/10.1056/NEJMoa2310610.
• 02:00
  Electronic nudges increase influenza vaccination utilization after myocardial infarction: the nationwide NUDGE-FLU implementation trial Eur Heart J
  ImplementationInfluenzaVaccineMyocardial infarctionRegistry
• 02:00
  Imaging of the brain–heart axis: prognostic value in a European setting Eur Heart J
  AbstractBackground and AimsIncreasing data suggest that stress-related neural activity (SNA) is associated with subsequent major adverse cardiovascular events (MACE) and may represent a therapeutic target. Current evidence is exclusively based on populations from the U.S. and Asia where (...)
• 02:00
  Unveiling the heart’s silent whisperer: study of stress and the brain–heart connection in Europe Eur Heart J
• 02:00
  Low-dose colchicine for atherosclerosis: long-term safety Eur Heart J
  AbstractLow-dose colchicine (0.5 mg daily) is now FDA-approved for secondary prevention in patients with coronary disease and will be increasingly prescribed in clinical practice. In this State-of-the-Art Review, data were collated from contemporary systemic reviews of case reports, drug (...)

9 avril

Eur Heart J https://academic.oup.com/site_5375/

• 02:00
  Inflammatory cardiomyopathy: searching an infrequent cause Eur Heart J
• 02:00
  Use of new and emerging cancer drugs: what the cardiologist needs to know Eur Heart J
  AbstractThe last decade has witnessed a paradigm shift in cancer therapy, from non-specific cytotoxic chemotherapies to agents targeting specific molecular mechanisms. Nonetheless, cardiovascular toxicity of cancer therapies remains an important concern. This is particularly relevant given the (...)
• 02:00
  Calmodulin, sudden death, and the Folbigg case: genes in court Eur Heart J
• 02:00
  Oral anticoagulation in device-detected atrial fibrillation: effects of age, sex, cardiovascular comorbidities, and kidney function on outcomes in the NOAH-AFNET 6 trial Eur Heart J
  Atrial high-rate episodesDevice-detected atrial fibrillationStrokeAtrial fibrillationCHA2DS2-VASc scoreKidney functionNOAH-AFNET 6AnticoagulationBleeding
• 02:00
  Social Determinants of Cardiovascular Health: understanding their impact and transitioning to a holistic care approach Eur Heart J
  As part of their sustainable development goals, the United Nations (UN) aims to achieve a one-third reduction in premature mortality attributed to non-communicable chronic diseases, such as cardiovascular disease (CVD), by the year 2030.1 Solely concentrating on established chronic disease (...)
• 02:00
  Inorganic nitrate: a game changer in preventing contrast-associated acute kidney injury Eur Heart J
• 02:00
  Infection, inflammation, and cardiovascular risk: are we underestimating an old disease? Eur Heart J

7 avril

Eur Heart J https://academic.oup.com/site_5375/

• 02:00
  Coronary bypass surgery guided by computed tomography in a low-risk population Eur Heart J
  AbstractBackground and AimsIn patients with three-vessel disease and/or left main disease, selecting revascularization strategy based on coronary computed tomography angiography (CCTA) has a high level of virtual agreement with treatment decisions based on invasive coronary angiography (...)
• 02:00
  Coronary angiography and bypass surgery: born together and now going separate ways? Eur Heart J

4 avril

Eur Heart J https://academic.oup.com/site_5375/

• 02:00
  Catheter-based therapy for high-risk or intermediate-risk pulmonary embolism: death and re-hospitalization Eur Heart J
  AbstractBackground and AimsCatheter-based therapies (CBTs) have been developed as a treatment option in patients with pulmonary embolism (PE). There remains a paucity of data to inform decision-making in patients with intermediate-risk or high-risk PE. The aim of this study was to characterize (...)

3 avril

Eur Heart J https://academic.oup.com/site_5375/

• 02:00
  Weekly journal scan: it takes two for acute stroke Eur Heart J
  Comment on the article ‘Dual antiplatelet treatment up to 72 h after ischemic stroke’ published in The New England Journal of Medicine; https://doi.org/10.1056/NEJMoa2309137.
• 02:00
  Cardio-obstetrics: a new specialty Eur Heart J
  Since the middle of the 20th century, cardiology has expanded enormously, both in breadth and in depth. Included among these advances are important interactions between the cardiovascular (CV) and other organ systems. I became aware of one of these early interactions in 1953 during my first (...)
• 02:00
  Syphilis and cardiovascular risk: a Taiwanese registry Eur Heart J
  AbstractBackground and AimsStudies on the impact of syphilis on the cardiovascular system in large populations are limited. This study investigated the effects of syphilis on cardiovascular outcomes.MethodsMedical records from 2010 to 2015 were retrieved from the Taiwan National Health (...)

1er avril

Eur Heart J https://academic.oup.com/site_5375/

• 02:00
  Weekly journal scan: the KCa2 potassium channel as a promising target for the pharmacologic cardioversion of atrial fibrillation Eur Heart J
  Comment on the article ‘Inhibition of the KCa2 potassium channel in atrial fibrillation: a randomized phase 2 trial’, which was published in Nature Med; https://doi.org/10.1038/s41591-023-02679-9.

30 mars

Eur Heart J https://academic.oup.com/site_5375/

• 01:00
  A streamlined pathway for transcatheter aortic valve implantation: the BENCHMARK study Eur Heart J
  AbstractBackground and AimsThere is significant potential to streamline the clinical pathway for patients undergoing transcatheter aortic valve implantation (TAVI). The purpose of this study was to evaluate the effect of implementing BENCHMARK best practices on the efficiency and safety of (...)

29 mars

Eur Heart J https://academic.oup.com/site_5375/

• 01:00
  LuX-Valve Plus transcatheter tricuspid valve replacement for massive tricuspid flail after lead extraction Eur Heart J
  A 71-year-old male presented with New York Heart Association (NYHA) III dyspnoea and peripheral oedema. Medical history included primary prevention implantable cardioverter-defibrillator (ICD) with endocarditis requiring lead extraction resulting in torrential tricuspid regurgitation (Panels A (...)
• 01:00
  Integration of a polygenic score into guideline-recommended prediction of cardiovascular disease Eur Heart J
  AbstractBackground and AimsIt is not clear how a polygenic risk score (PRS) can be best combined with guideline-recommended tools for cardiovascular disease (CVD) risk prediction, e.g. SCORE2.MethodsA PRS for coronary artery disease (CAD) was calculated in participants of UK Biobank (n = 432 (...)
• 01:00
  Correction to: Changes in frailty and incident cardiovascular disease in three prospective cohorts Eur Heart J
  This is a correction to: Di He, Zhaoping Wang, Jun Li, Kaixin Yu, Yusa He, Xinyue He, Yuanjiao Liu, Yuhao Li, Ruiyi Fu, Dan Zhou, Yimin Zhu, Changes in frailty and incident cardiovascular disease in three prospective cohorts, European Heart Journal, Volume 45, Issue 12, 21 March 2024, Pages (...)
• 01:00
  Correction to: Tricuspid valve disease and cardiac implantable electronic devices Eur Heart J
  This is a correction to: Martin Andreas et al., Tricuspid valve disease and cardiac implantable electronic devices, European Heart Journal, Volume 45, Issue 5, 1 February 2024, Pages 346–365, https://doi.org/10.1093/eurheartj/ehad783
• 01:00
  Patient–physician sex concordance and outcomes in cardiovascular disease: a systematic review Eur Heart J
  AbstractThe sex disparity in outcomes of patients with cardiovascular disease is well-described and has persisted across recent decades. While there have been several proposed mechanisms to explain this disparity, there are limited data on female patient–physician sex concordance and its (...)

28 mars

Eur Heart J https://academic.oup.com/site_5375/

• 01:00
  Weekly journal scan: a hard RAFTing to improve long-term survival in heart failure with severely reduced ejection fraction Eur Heart J
  Comment on the article ‘Long-term outcomes of resynchronization–defibrillation for heart failure’ published in the New England Journal of Medicine. doi: 10.1056/NEJMoa2304542.
• 01:00
  Correction to: Prednisone administration in inflammatory cardiomyopathy: caveat for potentially adverse myocardial actions Eur Heart J
  This is a correction to: Andrea Frustaci, Matteo Antonio Russo, Cristina Chimenti, Prednisone administration in inflammatory cardiomyopathy: caveat for potentially adverse myocardial actions, European Heart Journal, Volume 44, Issue 15, 14 April 2023, Page 1376, (...)
• 01:00
  Artificial intelligence-enhanced exposomics: novel insights into cardiovascular health Eur Heart J
• 01:00
  Artificial intelligence–based assessment of built environment from Google Street View and coronary artery disease prevalence Eur Heart J
  AbstractBackground and AimsBuilt environment plays an important role in the development of cardiovascular disease. Tools to evaluate the built environment using machine vision and informatic approaches have been limited. This study aimed to investigate the association between machine (...)

25 mars

Eur Heart J https://academic.oup.com/site_5375/

• 01:00
  A deep learning solution to detect left ventricular structural abnormalities with chest X-rays: towards trustworthy AI in cardiology Eur Heart J
• 01:00
  Correction to: Healthcare resource utilisation and safety outcomes in patients undergoing transcatheter mitral valve repair - A nationwide analysis Eur Heart J
  This is a correction to: T Thevathasan, S Berlinghof, D Elschenbroich, J M Wiedenhofer, A L Gaul, F Barbieri, U Landmesser, M Reinthaler, C Skurk, Healthcare resource utilisation and safety outcomes in patients undergoing transcatheter mitral valve repair - A nationwide analysis, European (...)

21 mars

Eur Heart J https://academic.oup.com/site_5375/

• 01:00
  Inorganic nitrate benefits contrast-induced nephropathy after coronary angiography for acute coronary syndromes: the NITRATE-CIN trial Eur Heart J
  AbstractBackground and AimsContrast-induced nephropathy (CIN), also known as contrast-associated acute kidney injury (CA-AKI) underlies a significant proportion of the morbidity and mortality following coronary angiographic procedures in high-risk patients and remains a significant unmet need. (...)

20 mars

Eur Heart J https://academic.oup.com/site_5375/

• 01:00
  Deep learning to detect left ventricular structural abnormalities in chest X-rays Eur Heart J
  AbstractBackground and AimsEarly identification of cardiac structural abnormalities indicative of heart failure is crucial to improving patient outcomes. Chest X-rays (CXRs) are routinely conducted on a broad population of patients, presenting an opportunity to build scalable screening tools (...)

15 mars

Eur Heart J https://academic.oup.com/site_5375/

• 01:00
  The year in cardiovascular medicine 2023: the top 10 papers in thrombosis and antithrombotic treatment Eur Heart J
• 01:00
  Cardioprotection research has left its comfort zone Eur Heart J
• 01:00
  Recombinant human soluble domain of CD39L3 and ticagrelor: cardioprotective effects in experimental myocardial infarction Eur Heart J
  AbstractBackground and AimsThe ecto–nucleoside triphosphate diphosphohydrolases of the CD39 family degrade ATP and ADP into AMP, which is converted into adenosine by the extracellular CD73/ecto-5-nucleotidase. This pathway has been explored in antithrombotic treatments but little in myocardial (...)

6 mars

Eur Heart J https://academic.oup.com/site_5375/

• 01:00
  Stable incidence and outcomes for patients with incident aortic stenosis: how can we translate excellent trial data into improved clinical outcomes in the population? Eur Heart J

5 mars

Eur Heart J https://academic.oup.com/site_5375/

• 01:00
  Cardiac magnetic resonance in the assessment of the anomalous right coronary artery originating from the left sinus of Valsalva Eur Heart J
  AAOCAACAOSAAORCAVentricular arrhythmiasCMRLGESCD
• 01:00
  Inhibition of miR-21: cardioprotective effects in human failing myocardium ex vivo Eur Heart J
  ERC10.13039/501100000781SFB1470
• 01:00
  Treatments for pulmonary arterial hypertension: navigating through a network of choices Eur Heart J
• 01:00
  Usefulness of endomyocardial biopsy using three-dimensional delivery system for the diagnosis of cardiac amyloidosis with complete atrioventricular block after transcatheter aortic valve implantation Eur Heart J
• 01:00
  Benefits of coronary artery bypass grafting over percutaneous coronary intervention in left main disease: the strength of the evidence Eur Heart J
  This commentary refers to ‘PCI or CABG for left main coronary artery disease: the SWEDEHEART registry’, by J. Persson et al., https://doi.org/10.1093/eurheartj/ehad369.

4 mars

Eur Heart J https://academic.oup.com/site_5375/

• 01:00
  Weekly journal scan: do biodegradable polymer stents provide a durable benefit in patients with ST-segment elevation myocardial infarction? Eur Heart J
  Comment on the article ‘Long-term outcomes with biodegradable polymer sirolimus-eluting stents vs. durable polymer everolimus-eluting stents in ST-segment elevation myocardial infarction: 5-year follow-up of the BIOSTEMI randomised superiority trial’, which was published in The Lancet. (...)
• 01:00
  Weekly journal scan: a new small-interfering RNA to fight a genetic cardiovascular risk factor Eur Heart J
  Comment on the article ‘Lepodisiran, an Extended-Duration Short Interfering RNA Targeting Lipoprotein(a): A Randomized Dose-Ascending Clinical Trial’, which was published in JAMA. https://doi.org/10.1001/jama.2023.21835.

1er mars

Eur Heart J https://academic.oup.com/site_5375/

• 01:00
  Inadvertent intracoronary pacemaker lead implantation Eur Heart J
• 01:00
  Arm and ankle blood pressure indices, and peripheral artery disease, and mortality: a cohort study Eur Heart J
  AbstractBackground and AimsFew studies have compared arm and ankle blood pressures (BPs) with regard to peripheral artery disease (PAD) and mortality. These relationships were assessed using data from three large prospective clinical trials.MethodsBaseline BP indices included arm systolic BP (...)
• 01:00
  Rheumatoid arthritis and peripartum cardiovascular complications: focusing on non-traditional cardiovascular risk factors to improve maternal outcomes Eur Heart J
• 01:00
  Rheumatoid arthritis and cardiovascular complications during delivery: a United States inpatient analysis Eur Heart J
  AbstractBackground and AimsPersons with rheumatoid arthritis (RA) have an increased risk of obstetric-associated complications, as well as long-term cardiovascular (CV) risk. Hence, the aim was to evaluate the association of RA with acute CV complications during delivery admissions.MethodsData (...)

28 février

Eur Heart J https://academic.oup.com/site_5375/

• 01:00
  Pulmonary arterial hypertension treatment: an individual participant data network meta-analysis Eur Heart J
  AbstractBackground and AimsEffective therapies that target three main signalling pathways are approved to treat pulmonary arterial hypertension (PAH). However, there are few large patient-level studies that compare the effectiveness of these pathways. The aim of this analysis was to compare (...)

17 février

Eur Heart J https://academic.oup.com/site_5375/

• 01:00
  Tackling metabolic defects in HFpEF Eur Heart J
  German Centre for Cardiovascular Research10.13039/10001044781X3100210Deutsche Forschungsgemeinschaft10.13039/501100001659DFG10.13039/100004807German Research Foundation10.13039/5011000016591470—A02European Research Council10.13039/501100000781101078307

16 février

Eur Heart J https://academic.oup.com/site_5375/

• 01:00
  Correction to: Cardiovascular hospitalizations and mortality among adults aged 25–64 years in the USA Eur Heart J
  This is a correction to: Chantal M Henry, Andrew S Oseran, ZhaoNian Zheng, Huaying Dong, Rishi K Wadhera, Cardiovascular hospitalizations and mortality among adults aged 25–64 years in the USA, European Heart Journal, Volume 45, Issue 12, 21 March 2024, Pages 1017–1026, (...)

15 février

Eur Heart J https://academic.oup.com/site_5375/

• 01:00
  Aspiration as inspiration for uncommon infective endocarditis treatment Eur Heart J
• 01:00
  Fish bone ingestion causes aortic pseudoaneurysm Eur Heart J
• 01:00
  A rare case of haemorrhagic left atrial bouncing ball myxoma Eur Heart J
  A 56-year-old male without any history of cardiac or systemic disease was referred for a 6-day history of sudden onset left-sided weakness. The physical examination revealed a low-frequency diastolic heart murmur at the apex. He exhibited grade III left limb muscle strength, and 12-lead ECG (...)
• 01:00
  Injury minimization after myocardial infarction: focus on extracellular vesicles Eur Heart J
  AbstractDespite improvements in clinical outcomes following acute myocardial infarction, mortality remains high, especially in patients with severely reduced left ventricular ejection fraction (LVEF
• 01:00
  Efficacy of paclitaxel-coated balloon angioplasty combined with intensive lipid-lowering therapy for ST-segment elevation myocardial infarction: insights from near-infrared spectroscopy Eur Heart J

10 février

Eur Heart J https://academic.oup.com/site_5375/

• 01:00
  Cardiac cryptographers: cracking the code of the epitranscriptome Eur Heart J
  Independent from the nucleotide sequence dictated by DNA, native RNA is full of information, coated with over 170 chemical modifications (collectively known as the epitranscriptome) that modulate its stability, localization, translation efficiency, and many more facets of RNA processing, (…)
• 01:00
  Advancing cardiovascular research: Gemma Vilahur talks about her pioneering heart health discoveries Eur Heart J
  Gemma Vilahur DVM, PhD, is a group leader at the Research Institute Hospital de la Santa Creu I Sant Pau (IR-HSCSP) in Barcelona, Spain. A veterinarian by training, she has a PhD in cardiovascular medicine and her research focuses on elucidating the basic mechanisms underlying vascular and heart (…)
• 01:00
  How artificial intelligence can assist with ischaemic heart disease Eur Heart J
  World Bank10.13039/100004421Government of the Republic of Uzbekistan
• 01:00
  Impact of topology on the number of loops during macro-re-entrant atrial tachycardia Eur Heart J

8 février

Eur Heart J https://academic.oup.com/site_5375/

• 01:00
  Transcatheter mitral valve replacement at an inflection point: lessons learned and the path forward Eur Heart J
  Transcatheter mitral valve replacement (TMVR) is emerging as a therapeutic alternative for high-risk symptomatic mitral regurgitation (MR) patients. Early in its development, TMVR promised to provide more complete, predictable, and durable MR elimination even in complicated anatomies. However, (...)
• 01:00
  Hypertension and the kidney: an update Eur Heart J
  Arterial hypertension is the top risk factor for attributable deaths. The kidney and hypertension are intimately ligated. Thus, a defective kidney function contributes to the initial increase in blood pressure (BP) while arterial hypertension promotes the development and progression of left (...)

6 février

Eur Heart J https://academic.oup.com/site_5375/

• 01:00
  Multimodality imaging of acute intramyocardial dissecting haematoma and its dynamic progression Eur Heart J
  A 65-year-old man was hospitalized 9 h later after a transient syncope. Electrocardiogram displayed abnormal Q-waves in the inferior wall, accompanied by modest elevation of the ST-segment. Coronary angiography showed an occlusive stenosis in the first obtuse marginal artery. Transthoracic (...)

30 janvier

Eur Heart J https://academic.oup.com/site_5375/

• 01:00
  Mitochondria and the heart Eur Heart J
  Cardiac work demands a substantial amount of energy, stored in adenosine triphosphate (ATP), necessary for both contraction and relaxation. To meet these energy requirements, the heart is equipped with an efficient metabolic machinery. Mitochondria, the central organelle in maintaining cardiac (...)
• 01:00
  In memoriam to Professor Jean-Philippe Collet Eur Heart J
  It is with extreme sadness that we pay tribute to Professor Jean-Philippe Collet, who passed away on the evening of 15 December 2023. Our comrade, a beloved colleague, a friend, and a mentor to many did not survive a cardiac arrest, a terrible situation he fought all his life for his patients.
• 01:00
  Celebrating a journey of 75 years: highlights from the Cardiological Society of India’s Annual Conference of 2023 Eur Heart J
  The 2023 Annual Conference of Cardiological Society of India (CSI) was held in Kolkata, West Bengal, on 7–10 December 2023. Marking the Society’s Platinum Jubilee, the Conference unfolded with grandeur under the able stewardship of Dr P.C. Rath, Scientific Chairman, and Dr D.P. Sinha, (...)
• 01:00
  A translational approach towards understanding brain waste clearance in cerebral amyloid angiopathy Eur Heart J

29 janvier

Eur Heart J https://academic.oup.com/site_5375/

• 01:00
  Deceased donor organ retrieval: impact on cardiovascular research Eur Heart J

25 janvier

Eur Heart J https://academic.oup.com/site_5375/

• 01:00
  Critical 11 min in contrast-enhanced computed tomography for acute aortic dissection Eur Heart J
• 01:00
  Myocardial scar and remodelling predict long-term mortality in severe aortic stenosis beyond 10 years Eur Heart J
  Aortic valve stenosisMagnetic resonance imagingMortalityMyocardiumLate gadolinium enhancement
• 01:00
  Impact of untreated chronic obstructive coronary artery disease on outcomes after transcatheter aortic valve replacement Eur Heart J
  AbstractBackground and AimsIn transcatheter aortic valve replacement (TAVR) recipients, the optimal management of concomitant chronic obstructive coronary artery disease (CAD) remains unknown. Some advocate for pre-TAVR percutaneous coronary intervention, while others manage it expectantly. (...)

18 janvier

Eur Heart J https://academic.oup.com/site_5375/

• 01:00
  Functionally bicuspid aortic valve leads to myocardial ischaemia Eur Heart J
  A 46-year-old male with a 3-year history of chest discomfort and shortness of breath during physical activity was admitted to our centre. Echocardiography revealed a functionally bicuspid aortic valve (BAV), moderate aortic valve stenosis, and severe aortic regurgitation. Coronary artery (...)
• 01:00
  Involvement of cholesterol crystals in the mechanism of aortogenic cerebral infarction: an angioscopic study Eur Heart J

8 janvier

Eur Heart J https://academic.oup.com/site_5375/

• 01:00
  Severe aortic stenosis: secular trends of incidence and outcomes Eur Heart J
  AbstractBackground and AimsSevere aortic stenosis (AS) is the guideline-based indication for aortic valve replacement (AVR), which has markedly increased with transcatheter approaches, suggesting possible increasing AS incidence. However, reported secular trends of AS incidence remain (...)

28 décembre

Eur Heart J https://academic.oup.com/site_5375/

• 01:00
  Gastropericardial fistula complicated by severe multi-vessel coronary spasm Eur Heart J
  A 70-year-old man was admitted to our hospital for chest pain. He underwent oesophagectomy and gastric tube reconstruction for oesophageal cancer 17 years ago and had endoscopic clips inserted due to gastric tube ulcer complicated with bleeding 1 month ago. Electrocardiogram showed ST segment (...)

14 décembre

Eur Heart J https://academic.oup.com/site_5375/

• 01:00
  Acid-sensing ion channel 1a blockade reduces myocardial injury in rodent models of myocardial infarction Eur Heart J
  Ischemia-reperfusion injuryCardioprotectionHi1a